Literature DB >> 29132572

Secondary Gains: Advances in Neurotrauma Management.

Brit Long1, Alex Koyfman2.   

Abstract

Neurotrauma is a leading cause of death and is associated with many secondary injuries. A balance of mean arterial pressure (MAP) and intracranial pressure (ICP) is required to ensure adequate cerebral blood flow and cerebral perfusion pressure. Evaluation and management in the emergency department entails initial stabilization and resuscitation while assessing neurologic status. ICP management follows a tiered approach. Intubation requires consideration of preoxygenation, head of bed elevation, first pass success, and adequate analgesia and sedation. Early consultation with neurosurgery is needed for definitive therapy. Focused evaluation and management play a significant role in optimizing patient outcomes. Published by Elsevier Inc.

Entities:  

Keywords:  Intracranial pressure; Mean arterial pressure; Neurotrauma; Spinal cord injury; Tier; Traumatic brain injury

Mesh:

Year:  2018        PMID: 29132572     DOI: 10.1016/j.emc.2017.08.007

Source DB:  PubMed          Journal:  Emerg Med Clin North Am        ISSN: 0733-8627            Impact factor:   2.264


  3 in total

Review 1.  Secondary Mechanisms of Neurotrauma: A Closer Look at the Evidence.

Authors:  Sina Aghili-Mehrizi; Eric Williams; Sandra Yan; Matthew Willman; Jonathan Willman; Brandon Lucke-Wold
Journal:  Diseases       Date:  2022-05-23

2.  Diagnosis of elevated intracranial pressure in critically ill adults: systematic review and meta-analysis.

Authors:  Shannon M Fernando; Alexandre Tran; Wei Cheng; Bram Rochwerg; Monica Taljaard; Kwadwo Kyeremanteng; Shane W English; Mypinder S Sekhon; Donald E G Griesdale; Dar Dowlatshahi; Victoria A McCredie; Eelco F M Wijdicks; Saleh A Almenawer; Kenji Inaba; Venkatakrishna Rajajee; Jeffrey J Perry
Journal:  BMJ       Date:  2019-07-24

3.  A mathematical model for predicting intracranial pressure based on noninvasively acquired PC-MRI parameters in communicating hydrocephalus.

Authors:  Jia Long; Deshun Sun; Xi Zhou; Xianjian Huang; Jiani Hu; Jun Xia; Guang Yang
Journal:  J Clin Monit Comput       Date:  2020-10-01       Impact factor: 1.977

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.